Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-129769
Filing Date
2023-12-27
Accepted
2023-12-27 17:37:18
Documents
1
Period of Report
2023-12-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2333785-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2333785-3_4seq1.xml 4 12923
  Complete submission text file 0001104659-23-129769.txt   14480
Mailing Address C/O TETRAPHASE PHARMACEUTICALS, INC. 480 ARSENAL STREET, SUITE 110 WATERTOWN MA 02472
Business Address
Lubner David Charles (Reporting) CIK: 0001572000 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39373 | Film No.: 231518914

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Issuer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)